20 studies found for:    opt-80
Show Display Options
Rank Status Study
1 Recruiting A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
Condition: Clostridium Difficile
Interventions: Drug: OPT-80;   Drug: vancomycin
2 Completed OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)
Condition: Diarrhea
Intervention: Drug: OPT-80
3 Completed
Has Results
PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
Conditions: Clostridium Infections;   Diarrhea
Interventions: Drug: PAR-101/OPT-80;   Drug: Vancomycin
4 Completed A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects
Conditions: Pharmacokinetics of Fidaxomicin;   Healthy Subjects
Interventions: Drug: Fidaxomicin;   Drug: Placebo
5 Recruiting Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Condition: Clostridium Difficile-Associated Diarrhea (CDAD)
Interventions: Drug: fidaxomicin;   Drug: placebo
6 Completed Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
Condition: Clostridium Difficile-associated Diarrhea
Intervention: Drug: fidaxomicin
7 Completed
Has Results
Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
Conditions: Clostridium Infections;   Diarrhea
Interventions: Drug: fidaxomicin;   Drug: Vancomycin
8 Completed Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5
Condition: Hypertension
Interventions: Drug: Fixed dose combination telmisartan 80 mg + HCTZ 25 mg;   Drug: Fixed dose combination telmisartan 80 mg + HCTZ 12.5 mg
9 Completed Optimization of Selenoprotein P in Chinese Subjects
Condition: Selenium Deficiency
Interventions: Dietary Supplement: 20 µg selenium;   Dietary Supplement: 40 µg selenium;   Dietary Supplement: 60 µg selenium;   Dietary Supplement: 80 µg selenium;   Dietary Supplement: 100 µg selenium;   Dietary Supplement: 120 µg selenium;   Dietary Supplement: placebo
10 Completed
Has Results
Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED)
Condition: Chemotherapy-Induced Nausea and Vomiting
Interventions: Drug: aprepitant;   Drug: Comparator: ondansetron;   Drug: Comparator: dexamethasone;   Drug: Comparator: fosaprepitant dimeglumine;   Drug: Comparator; Placebo (unspecified)
11 Completed
Has Results
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: CP 690,550 5 mg;   Drug: CP 690,550 10 mg;   Biological: Etanercept 50 mg;   Other: Placebo
12 Completed Social Work Intervention Focused on Transitions
Conditions: Study Focus: 30-day Rehospitalizations Among At-risk Older Adults Randomized to a Social Work-driven Care Transitions Intervention;   Heart Disease;   Diabetes;   Hypertension;   Cancer;   Depression;   Asthma;   Chronic Heart Failure;   Chronic Obstructive Pulmonary Disease;   Stroke
Intervention: Other: SWIFT home intervention
13 Terminated
Has Results
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Conditions: Sickle Cell Disease;   Pulmonary Hypertension
Interventions: Drug: Sildenafil;   Drug: Placebo
14 Unknown  HIV Indicator Diseases Survey Across Europe - UK Arm
Conditions: HIV;   AIDS;   Indicator Diseases/Indicator Conditions
Interventions: Other: HIV test (serological or salivary);   Other: Interview
15 Recruiting Belimumab in Remission of VASculitis
Condition: Vasculitis
Interventions: Biological: Placebo;   Biological: Belimumab 10 mg/kg;   Drug: Azathioprine
16 Active, not recruiting Video-Based Education for Dermatology Patients on Systemic Corticosteroids
Condition: Chronic Inflammatory Skin Diseases
Interventions: Behavioral: Video;   Behavioral: Standard Script
17 Not yet recruiting Prehospital Tranexamic Acid Use for Traumatic Brain Injury
Condition: Traumatic Brain Injury
Interventions: Drug: 1 gram Tranexamic Acid (TXA);   Drug: 2 grams TXA;   Drug: 0.9% Sodium Chloride injectable
18 Completed AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: bevacizumab [Avastin];   Drug: liposomal doxorubicin;   Drug: paclitaxel;   Drug: topotecan
19 Completed A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
Conditions: Advanced Solid Tumors;   Kidney Disease;   Renal Impairment
Interventions: Drug: AMG 386 + Paclitaxel;   Drug: AMG 386
20 Completed Study Comparing the Effectiveness of Incentives on Physical Activity Behavior in a Health Insured Population
Conditions: Physical Activity Behavior;   Wellness Programs
Intervention: Behavioral: Financial incentives

Indicates status has not been verified in more than two years